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Abstract
Background: In 2006, a cluster of malaria deaths in the highly endemic Jalpaiguri district, West
Bengal, India, led to assignment of additional resources. Malaria deaths decreased, but continued to
occur. A study was conducted to identify the risk factors for residual malaria deaths.
Methods:  Malaria death was defined as a death from fever with microscopically confirmed
Plasmodium falciparum among residents of Jalpaiguri during 2007–2008. For each case, three age-,
sex- and locality-matched controls were recruited among microscopically confirmed falciparum
malaria patients cured during the same period. Clinical and treatment information was abstracted
from records. Information about knowledge about malaria, presence of bed nets and DDT spraying
was collected through interviews of the close relatives of study subjects. Odds ratio (OR) were
calculated using multivariate methods.
Results: 51 malaria deaths were matched with 153 controls, which did not differ by age (median:
35 versus 36 years) and proportion of males (63% versus 63%). On multiple logistic regression
analysis, compared with survivors, malaria deaths were more likely to have been admitted with
already existing complications [OR = 4.1, 95% confidence interval (CI) = 1.6–10)], treated at a
private facility (OR = 3.7, 95% CI = 1.2–12), received treatment after 48 hours of fever onset (OR
= 14, 95% CI = 2.9–64), received chloroquine (OR = 13.3, 95% CI = 3.7–47). Households of the
deceased were also more likely to miss bed nets (OR = 6.3, 95% CI = 1.9–24) and DDT spraying
(OR = 9.2, 95% CI = 2.8–31).
Conclusion: Elimination of malaria deaths will require education of providers for prompt referral
before complications, engagement of the private sector, community awareness for early treatment
as well as scaled-up use of bed nets use and DDT. Use of newer generation anti-malarials must to
be generalized.
Background
Effective malaria controls depends on early diagnosis and
treatment, vector control and personal protection [1,2].
The objectives of a treatment policy are to ensure rapid
cure, reduce morbidity and eliminate mortality through
preventing the progression of uncomplicated malaria into
severe, potentially fatal disease [1,3]. Chloroquine, used
to be the mainstay of anti-malarial treatment. However,
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growing resistance led the World Health Organization to
recommend that all uncomplicated falciparum infections
be treated with an artemisinin-based combination ther-
apy (ACT). Patients suffering from severe malaria present-
ing in primary health care facilities should be provided
pre-referral treatment and transferred for full parenteral
treatment and supportive care [2,3].
In 2007, the Indian National Vector-borne Disease Con-
trol Programme (NVBDCP) reported 1,502,742 malaria
cases and 1,274 deaths [4]. However, cases and especially
deaths may be under-reported. Reasons for under-report-
ing include management of two thirds of the patients by
the private sector, absence of routine death certification in
rural areas and poor infrastructure for malaria diagnosis
in public health care facilities.
Jalpaiguri district, in the North of the West Bengal state,
experiences perennial malaria transmission. During an
outbreak in 2003, 842,409 clinical malaria cases and 149
deaths were reported. A 2003 drug resistance study
reported 86% treatment failure to chloroquine among fal-
ciparum malaria cases. During a subsequent malaria out-
break in 2006, 62,020 confirmed malaria cases and 97
deaths were reported [Government of West Bengal,
department of health, unpublished data]. During this out-
break, 40% of the cases and all malaria deaths were due to
Plasmodium falciparum infection. Review of malaria con-
trol activities in the Alipurduar sub-division of the district
(that reported 67 malaria deaths in 2006) pointed to
inadequate human resources funds and logistics [5]. Defi-
ciencies in the public health care system that normally
managed malaria through case finding and treatment had
led to a shift towards unqualified private practitioners,
leading to poor management, which may have contrib-
uted to deaths [5]. The department of health took several
measures to address deficiencies identified. It increased
inputs for early diagnosis and treatment for patients
attending public health facilities, vector control and per-
sonal protection measures: The number of malaria labora-
tory technicians in the district increased from 56 to 94
between 2006 and 2007 (an increase of 164%) and rapid
diagnostic kits were provided for early diagnosis. Between
2006 and 2007, number of villages with drug treatment
centres also increased from 899 to 1,284 (an increase of
70%). ACT (artesunate + sulphadoxine- pyrimethamine)
coverage among falciparum patients attending public
health facilities increased from 0% to 67%. In addition,
the coverage of insecticide-impregnated bet nets among
persons below the poverty lined increased from 0% to
21% during the same time period. However, the coverage
of residual spraying with DDT decreased from 48% to
18% [Government of West Bengal, department of health,
unpublished data]. Overall, the number of reported
deaths reduced by 52% between 2006 and 2007, but they
continued to be reported. Thus, a study was undertaken to
identify the risk factors associated with a fatal outcome
among patients with falciparum malaria (No deaths were
reported among patient with Plasmodium vivax malaria).
Methods
Study population and design
A matched case-control study was conducted in Jalpaiguri
district, West Bengal (Projected 2007 population:
3,973,930).
Cases and controls
A malarial death case was defined as death in a febrile
patient with microscopically-confirmed P. falciparum
infection who resided in Jalpaiguri district between Janu-
ary 2007 and October 2008. Malaria deaths were recruited
from the registers of the District Medical Office (DMO).
Microscopically-confirmed falciparum malaria patients
who were cured after treatment from January 2007 to
October 2008 were considered as controls. To obtain
these controls, surviving P. falciparum positive patients
identified during the study period in different health care
facilities were line-listed. From this sampling frame, three
age- (± 5 years), sex- and locality-matched controls were
selected for each malaria death case.
Sample size
Assuming a prevalence of exposure among controls of
20% (i.e., treatment in the private sector), choosing a con-
fidence interval (CI) of 95%, deciding for a power of 80%
and opting for 3 controls per cases, the required sample
size was 42 cases and 126 controls to detect an odds ratio
of three. Anticipating a non-response of 10%, plans were
made to recruit 47 cases and 141 controls.
Data collection
Information about demographic and clinical characteris-
tics as well as treatment details were abstracted from the
'malaria death investigation form' available for every
malaria death case. For controls, demographic, clinical
and treatment details were abstracted from hospital
admission records and the malaria register. Information
regarding knowledge, attitude, practices regarding malaria
(including health-seeking behaviour during the last fever
episode), personal protection and vector control meas-
ures was collected through interviews of close relatives of
the death cases and controls. A pre-tested structured ques-
tionnaire was used to collect all information.
Data analysis
The data analysis included calculation of age and sex-spe-
cific malaria death rates per 100,000 population using the
projected population for 2007 as denominator and distri-
bution of malaria deaths by month in 2007. With respect
to health seeking behaviour, the study made two levels ofMalaria Journal 2009, 8:133 http://www.malariajournal.com/content/8/1/133
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comparison. First, it differentiated public health care facil-
ities (sub-centres, primary health care centres, block pri-
mary health centres and hospitals) from private facilities
(tea garden clinics and private hospitals). Second, it differ-
entiated primary care (sub-centres, primary health care,
block primary health centre in the public sector and tea
garden clinics in the private sector) versus higher levels
(public and private hospitals). A univariate analysis was
used to calculate matched odds ratio (MOR) and their
95% confidence intervals (CI). After checking that there
were no major differences between the crude and matched
odds ratios in univariate analysis, variables with p value <
0.2 in univariate analysis and those of importance from a
biological plausibility stand point were then included
into a un-conditional logistic regression model as the con-
ditional logistic regression model was unstable. All data
analysis was conducted using Epi-info (version 3.5.1).
Human subjects protection
The institutional ethics committee of the National Insti-
tute of Epidemiology, Chennai approved the study proto-
col. Written informed consent was obtained from the
relatives of cases and controls before interviews.
Results
Descriptive epidemiology
In Jalpaiguri district, 51 malaria deaths were reported from
January 2007 to October 2008 (Cumulated incidence of
death over 22 months: 1.3 per 100,000). Malaria deaths
were more common among males (1.5 per 100,000) and
children under five years of age (2.3 per 100,000, Table 1).
In 2007, malaria deaths occurred throughout the year,
peaked during the rains, between May and July. They were
reported from 11 out of 13 blocks. Blocks with high inci-
dence of malaria deaths were remote, covered with tea
plantations or forests, populated by poor people who often
had to rely on the informal private sector or on private
health care facilities in tea gardens.
Analytic epidemiology
The 51 malaria death cases were matched with 153 controls.
Cases and controls did not differ by age (Median: 35 versus 36
years) and proportion of males (63% versus 63%). Compared
with survivors, malaria deaths were more likely to have been
admitted with clinical manifestations of severe malaria
(defined as unconsciousness, convulsions, coma, respiratory
distress, circulatory collapse, haemoglobinuria and jaundice
[6], MOR = 5.7, 95% CI = 2.5–13), to have been treated in the
private sector (i.e., Non-government health care facilities,
often staffed with poorly qualified health care workers, MOR
= 17, 95% CI, 5.1–56) and to have received anti-malarial treat-
ment > 48 hours after fever onset (MOR = 19, 95% CI = 2.1–
170). Malarial deaths were more likely to have received chlo-
roquine (MOR = 6.4, 95% CI = 2.6–15) and to live in houses
without bed nets (treated or untreated, MOR = 5.8, 95% CI =
2.4–14). Absence of visits by health workers (MOR = 8.6, 95%
CI = 2.3–32) and absence of DDT spraying in the house were
also significantly associated with malarial death (MOR = 2.6,
95% CI = 1.3–5.2, Table 2).
Variables significantly associated with malarial deaths in
unconditional logistic regression model included pres-
ence of complications already upon admission (adjusted
odds ratio [AOR] = 4.1, 95% CI = 1.6–10), management
in the private sector (AOR = 3.7, 95% CI = 1.2 – 12),
delayed anti-malaria treatment (AOR = 14, 95% CI = 2.9–
64), use of chloroquine (AOR = 13, 95% CI = 3.7–47),
absence of bed nets in the house (AOR = 6.3, 95% CI =
1.9–24) and absence of DDT spraying in the household
(AOR = 9.2, 95% CI = 2.9–31, Table 3.)
Discussion
Patients diagnosed with malaria, should be treated early
with safe and effective anti-malarial drugs, preferably
within 24 hours of the onset of symptoms [6]. Inadequate
and delayed treatment of uncomplicated malaria, espe-
cially in the non-immune patient may result in progres-
sion to severe malaria, which is associated with a high case
fatality rate. In India, delay in treatment as well as pres-
ence of complications on admission were found to be key
determinants of mortality [7-9].
In Jalpaiguri, delay in starting the anti-malarial treatment
48 hours after fever onset was significantly associated with
Table 1: Cumulated malaria mortality incidence by age and sex, Jalpaiguri district, West Bengal, India, January 2007–October 2008
Demographic characteristics Malaria deaths 2007 population Mortality (per 100,000 population) *
Age group < 5 year 10 431,992 2.3
5–14 year 18 1,059,117 1.7
15–29 year 11 1,065,175 1.0
30–49 year 6 998,483 0.6
50 year + 6 419,163 1.4
Sex Male 31 2,046,504 1.5
Female 20 1,927,436 1.0
Total 51 3,973,930 1.3
Cumulative rate for 22 monthsMalaria Journal 2009, 8:133 http://www.malariajournal.com/content/8/1/133
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death among falciparum malaria patients. This delay may
be due to a combination of patient behaviour and health
care access/quality issues. The association between pres-
ence of complications of malaria on admission and
malaria death also suggests a delay in starting treatment.
Use of the appropriate anti-malarial drug is a key pre-req-
uisite for malaria control and mortality reduction [2,6].
Combination therapies are preferred as they delay the
emergence or spread of resistance [1,6]. ACT is highly effi-
cacious and recommended in endemic regions. Consider-
ing the past history of chloroquine resistance in the
district [10] and malarial deaths in 2006, ACT was made
available in the block primary health centres. However,
the results of the present study suggest that its use is still
insufficient (almost half of control-subjects in the study
received chloroquine) and that the failure to generalize
this new treatment protocol contributed to the persistence
of deaths.
As much as 30% of the population in the district resided
in tea gardens and received treatment from private clinics
there [5]. Malaria death was implicated with receiving
treatment from private facilities in a previous study in
Table 2: Frequency of selected exposures among cases and controls, Jalpaiguri district, West Bengal, India, 2007–8
Exposure variables Cases (n = 51) Controls (n = 153) MOR 95% CI
#% # %
Socio-demographic characteristics Living below poverty level 49 92 147 97 0.83 0.31–2.4
Being illiterate*, 43 84 132 86 0.82 0.32–2.3
Being in a daily worker family 24 47 59 39 1.7 0.84–4.3
Treatment Complications on admission 36 90 77 52 5.7 2.5–13
Treated at private facility 25 49 11 7 17 5.1–56
Treatment started >48 hours 11 22 15 10 19 2.1–170
Treated with chloroquine 44 86 73 48 6.4 2.6–15
Treated in primary care 45 78 142 54 0.56 0.19–1.67
Prevention in the last 12 months Household not sprayed with DDT 26 51 42 27 2.6 1.3–5.3
No bed net 40 78 63 41 5.8 2.4–14
No house visit by health workers 21 41 25 16 8.6 2.3–32
Knowledge Mosquito bite can cause malaria 1 2 15 10 0.22 0.03–1.4
Malaria is curable 2 4 5 3 1.1 0.22–6.1
Malaria causes anaemia 29 57 91 59 0.94 0.42–2.4
Fever may kill if not treated early 49 96 139 91 0.53 0.14–2.3
Blood test necessary when fever 2 4 10 6 0.83 0.31–2.4
Malaria affects children 3 6 27 18 0.82 0.32–2.3
Malaria affects pregnant women 3 6 2 1 1.7 0.84–4.3
ITN prevent malaria 5 10 10 6 5.7 2.5–13
Confidence interval
*For young children, the literacy status of the head of family was considered
*Defined as the incapacity to read and write in the local language
*Fever onset
*Knowledge of the case-patients (deceased) and control subjects (survivors) assessed indirectly by proxy interviews of family members in both 
situations to ensure comparability of the data collection method
*Insecticide-impregnated mosquito nets
Table 3: Exposures associated with malarial death in unconditional logistic regression, Jalpaiguri district, West Bengal, India, 2007–8
Characteristics Crude odds ratio Adjusted odds Ratio 95% confidence interval
Complications on admission 5.7 4.1 1.6–10
Treated at private facility 17 3.7 1.2–12
Treatment started >48 hours of fever onset 19 14 2.9–64
Treated with chloroquine 6.4 13 3.7–47
Household not equipped with bed nets 5.8 6.3 1.9–24
Household not sprayed with DDT 2.6 9.2 2.8–31Malaria Journal 2009, 8:133 http://www.malariajournal.com/content/8/1/133
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Orissa [7]. In 2006, a survey of practitioners in private
facilities in Jalpaiguri indicated that knowledge of malaria
treatment and dangers signs was sub-optimal and lower
than what was found in the public sector [5]. It is, there-
fore, necessary to educate the private providers in Jal-
paiguri about the need to use the right anti-malarial drugs.
This would not only reduce the case fatality but would
also prevent development of resistance. Further profes-
sional training must also address early referral in the case
of danger signs.
Not having at least one bed net in the house was associ-
ated with malaria death in this study. Use of bed nets is an
important measure to prevent malaria and is one of the
strategies of World Health Organization's Roll Back
Malaria programme [2]. Insecticide-treated nets can
reduce deaths in children by one fifth and episodes of
malaria by half [11]. However, since we compared
malaria deaths with malaria survivors, the reasons for the
protective effect of bed nets are unclear. One possibility
could be that bed nets reduced the intensity of infection.
The other possibility could be that ownership of bed net
was a surrogate marker of socio-economic status, through
residual confounding. Only two variables were examined
reflecting income: being the poverty line and belonging to
the family of a daily labourer. Following the 2006 cluster
of deaths, insecticide-treated bed nets were distributed.
However, in 2007, in high-risk areas, only 5% of the pop-
ulation and 21% of the below poverty line families were
covered. Furthermore, the proportion of houses coverage
of DDT spraying activities decreased from 48% in 2006 to
18% in 2007. This failure to spray was also a risk factor for
deaths in this study.
This study had a number of limitations. First, the informa-
tion about clinical and treatment details from cases and
controls was collected from available records instead of
prospectively. Second, the study only included malaria
deaths reported to the district medical officer. Malaria
deaths occurring in the private sector were probably less
likely to be reported than those occurring in the public
sector. Thus, the study may have underestimated the pro-
portion of death cases from the private sector. This limita-
tion would have led to an under-estimation of the true
odds ratio and does not affect the capacity of the study to
conclude. Third, it is possible that respondents' knowl-
edge about malaria and information about DDT spraying
might have been influenced by the clinical outcome of
study subjects. Fourth, presence of at least one bed net was
considered as a proxy for use of bed nets in the house, as
information about exact bed nets coverage in households
and use was not collected during the study.
In conclusion, malaria deaths continue to occur in Jal-
paiguri district despite additional investments in the anti-
malaria programme. Based on these findings, a number of
recommendations could be proposed. First, the Depart-
ment of Health needs to sustain the inputs provided in the
district in terms of rapid diagnostic kits, ACT and funds. It
is also necessary to reach sufficient coverage (80%) of bed
nets through more distribution, particularly to families
living below the poverty line. Second, medical officers in
primary care facilities need to be educated about early
referral of malaria cases presenting with complications.
Third, programme managers need to generate community
awareness about malaria, including the need to seek
prompt treatment for fever. Fourth, spray teams must
catch up with the setbacks observed in terms of DDT
spraying, particularly in high-risk areas. Fifth, private prac-
titioners must be educated about use of appropriate anti-
malarials, management of severe malaria and early refer-
ral. Specifically, to address issues in the private sector, an
intervention based upon a pilot public-private partner-
ship with tea plantations is now being considered in the
district. This intervention would include additional train-
ing to improve curative and preventative malaria control,
and an agreement by which ACT and bed nets could be
supplied to tea garden industry for better malaria case
management and prevention of transmission. Implemen-
tation of these measures must be monitored, including
impact assessments using surveillance data, so that
malaria deaths in Jalpaiguri can be eliminated.
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